Results 71 to 80 of about 83,600 (312)

Identification of a novel botulinum neurotoxin gene cluster in Enterococcus

open access: yesFEBS Letters, 2018
The deadly neurotoxins of Clostridium botulinum (BoNTs) comprise eight serotypes (A–G; X). The neurotoxin gene cluster encoding BoNT and its accessory proteins includes an operon containing an ntnh gene upstream of the boNT gene.
J. Brunt   +3 more
semanticscholar   +1 more source

Botulinum neurotoxins: Future innovations

open access: yesMedicine, 2023
Botulinum neurotoxins (BoNTs) are multi-domain proteins whose potent and selective actions on nerve endings have led to innovations in both basic and clinical science. The various BoNT domains are responsible for binding to gangliosides and proteins associated with nerve cell membranes, internalization into the cell, and cleavage of one or more SNARE (
Brideau-Andersen, Amy   +2 more
openaire   +2 more sources

Changes in severity and impact of drooling after submandibular gland botulinum neurotoxin A injections in children with neurodevelopmental disabilities

open access: yesDevelopmental Medicine & Child Neurology, 2019
To examine changes in objective and subjective drooling severity measures after submandibular botulinum neurotoxin A injection in children with neurodevelopmental disabilities, explore their relationship, and evaluate if clinically relevant responses ...
K. van Hulst   +4 more
semanticscholar   +1 more source

Challenging the Clostridium botulinum toxin type A (BoNT/A) with a selection of microorganisms by culture methods and extended storage of used vials to assess the loss of sterility [PDF]

open access: yes, 2015
In 2002, botulinum toxin type A (BoNT/A) was approved by the US Food and Drug Administration (FDA) for cosmetic use. However, there may be procedural differences between the ways in which a clinician handles, applies and stores the product compared to ...
Crean, Stjohn   +4 more
core  

Botulinum neurotoxin type C protease induces apoptosis in differentiated human neuroblastoma cells [PDF]

open access: yes, 2016
Neuroblastomas constitute a major cause of cancer-related deaths in young children. In recent years, a number of translation-inhibiting enzymes have been evaluated for killing neuroblastoma cells. Here we investigated the potential vulnerability of human
Binz, T.   +3 more
core   +1 more source

The Role of Botulinum Neurotoxin A in the Conservative Treatment of Fractures: An Experimental Study on Rats

open access: yesThe Scientific World Journal
This paper explores the role of botulinum neurotoxin in aiding fracture recovery through temporary muscle paralysis. Specifically, it investigates the effects of botulinum neurotoxin-induced paralysis of the sternocleidomastoid muscle on clavicle ...
Themistoklis Vampertzis   +6 more
doaj   +1 more source

Health‐Related Quality of Life in Relation to the 5‐2‐1 Criteria in Parkinson's Disease in Sweden

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Device‐aided therapies (DAT) offer alternatives to oral or transdermal dopaminergic treatments in advanced Parkinson's disease (PD), where they can reduce motor fluctuations and dyskinesia and improve health‐related quality of life (HRQoL).
Frida Hjalte   +5 more
wiley   +1 more source

Botulinum neurotoxin formulations: overcoming the confusion

open access: yesClinical, Cosmetic and Investigational Dermatology, 2018
Botulinum toxin A is produced by anaerobic spore-forming bacteria and is used for various therapeutic and cosmetic purposes. Botulinum toxin A injections are the most popular nonsurgical procedure worldwide.
Souphiyeh Samizadeh, K. De Boulle
semanticscholar   +1 more source

The usage of botulinum in the treatment of masticatory muscles hyperactivity

open access: yesJournal of Education, Health and Sport, 2022
Introduction and purpose: Masticatory muscles hyperactivity is currently a very common problem among adult population. The ignorance of the symptoms and the lack or unsuccessful treatment may lead to serious health complications, which lead to major ...
Martyna Drożak   +2 more
doaj   +1 more source

Muscle volume alterations after first botulinum neurotoxin A treatment in children with cerebral palsy: a 6‐month prospective cohort study

open access: yesDevelopmental Medicine & Child Neurology, 2018
This study aimed to track alterations in muscle volume for 6 months in children with cerebral palsy (CP) after the first exposure to botulinum neurotoxin A (BoNT‐A), a commonly used focal spasticity treatment.
C. Alexander   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy